Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹69.69
2.61 (3.89%)
High VOLATILITY
As on 12 Jun 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹147 Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
9.9
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹46.1+51.2%
52W High₹108.3-35.7%
Current Price
₹69.69
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹55.75
Upper Circuit₹83.63
Reference Price
₹69.69
Investment Checklist
Double Top on 1W (BREAKOUT CONFIRMED) — target ₹57.25
Triple Top on 1D (BREAKOUT CONFIRMED) — target ₹93.84
10/20 Bearish Cross detected 2 day(s) ago
EMA(9) Crossover: Price crossed above EMA(9): Fresh bullish momentum signal.
SuperTrend(10,3): Price above SuperTrend (Industry Standard (Swing/Medium-Term))
Technical Analysis
Technical Analysis
Analysis from 2026-06-12
Confidence
43%
Trend
NEUTRAL
NEUTRAL
Mixed MA signals — sideways/transition
EMA20
68.91
EMA50
67.88
EMA200
76.28
Price Action
DOWNTREND
BEARISH
Higher Highs3
Higher Lows3
Lower Highs6
Lower Lows6
Support & Resistance Levels
Resistance (Above)
₹70.69
₹72.21
₹75.02
₹76.18
₹79.89
Support (Below)
₹66.06
₹64.55
₹63.75
₹62.44
₹61.00
Volume Analysis
TrendSTABLE
Change-0.60%
Unusual VolumeNo
Recent MA Crossovers
10/20 Bearish Cross
2 days ago
SELL
Stop Loss Levels
Fixed Risk
1% Risk₹68.99
3% Risk₹67.60
5% Risk₹66.21
7% Risk (Custom)
₹64.81Technical Levels
1x ATR (Volatility)₹66.80
2x ATR (Swing)₹63.91
3x ATR (Trend)₹61.02
Immediate Support₹66.06
Moving Averages
EMA 9 (Short-term)₹68.81
EMA 20 (Medium-term)₹68.91
EMA 50 (Trend)₹67.88
Financials
Financial Analysis
| Metric | Dec '24 | Mar '25 | Jun '25 | Sep '25 |
|---|---|---|---|---|
| Revenue | ₹26.2 Cr | ₹39.1 Cr | ₹19.1 Cr | ₹26.3 Cr |
| Net Profit | ₹8.9 Cr | ₹-2.2 Cr | ₹11.8 Cr | ₹11,25,000 |
| EPS | ₹4.23 | — | ₹5.59 | ₹0.05 |
| Operating Profit | ₹9.5 Cr | ₹2.4 Cr | ₹12.4 Cr | ₹81,83,000 |
Peer Comparison
PharmaceuticalsPeer Comparison
| Symbol | Name | Price | Change |
|---|---|---|---|
| SUNPHARMA | Sun Pharmaceutical Industries Limited | ₹1,807.70 | +0.75% |
| DIVISLAB | Divi's Laboratories Limited | ₹6,638.00 | -0.26% |
| TORNTPHARM | Torrent Pharmaceuticals Limited | ₹4,571.20 | -0.02% |
| CIPLA | Cipla Limited | ₹1,389.40 | +0.44% |
| ZYDUSLIFE | Zydus Lifesciences Limited | ₹1,104.70 | -0.11% |
| DRREDDY | Dr. Reddy's Laboratories Limited | ₹1,275.40 | -0.05% |
| LUPIN | Lupin Limited | ₹2,293.30 | +0.88% |
| MANKIND | Mankind Pharma Limited | ₹2,381.10 | +0.35% |
| AUROPHARMA | Aurobindo Pharma Limited | ₹1,472.80 | +0.59% |
| LAURUSLABS | Laurus Labs Limited | ₹1,394.30 | +0.25% |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 20 Sept 2024 | Annual General Meeting | AGM |
| 21 Sept 2023 | Annual General Meeting | AGM |
| 20 Sept 2022 | Annual General Meeting | AGM |
| 20 Sept 2021 | Annual General Meeting | AGM |
| 18 Sept 2020 | Annual General Meeting | AGM |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for ALPA
View All
negative
ET Markets - Industry 88d ago
Pilots' body advisory: Ensure that airlines assess risk before planning flights in conflict-hit areas
ALPA India has put forth an important notice directed at pilots, emphasizing the necessity of conducting risk evaluations prior to approaching any conflict zones. As tensions rise in West Asia, it’s vital for pilots to recognize the rapidly shifting landscape of risks.
ALPAVITALChemicalsHealthcare